Vericel CorporationVCELNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR-20.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-20.8%/yr
vs +45.1%/yr prior
Acceleration
-65.9pp
Decelerating
Percentile
P50
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 11.15% |
| 2024 | 17.85% |
| 2023 | 5.51% |
| 2022 | 22.45% |
| 2021 | 25.09% |
| 2020 | -57.16% |
| 2019 | 123.48% |
| 2018 | 5.06% |
| 2017 | -15.37% |
| 2016 | -19.03% |